<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02861534</url>
  </required_header>
  <id_info>
    <org_study_id>1242-001</org_study_id>
    <secondary_id>2016-000671-25</secondary_id>
    <secondary_id>MK-1242-001</secondary_id>
    <nct_id>NCT02861534</nct_id>
  </id_info>
  <brief_title>A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)</brief_title>
  <acronym>VICTORIA</acronym>
  <official_title>A Randomized Parallel-Group, Placebo-Controlled, Double-Blind, Event-Driven, Multi-Center Pivotal Phase III Clinical Outcome Trial of Efficacy and Safety of the Oral sGC Stimulator Vericiguat in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF) - VerICiguaT GlObal Study in Subjects With Heart Failure With Reduced EjectIon FrAction (VICTORIA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bayer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Canadian VIGOUR Centre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Duke Clinical Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Merck Sharp &amp; Dohme Corp.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, placebo-controlled, parallel-group, multi-center, double-blind, event
      driven study of vericiguat (MK-1242) in participants with heart failure with reduced ejection
      fraction (HFrEF). The primary hypothesis is vericiguat (MK-1242) is superior to placebo in
      increasing the time to first occurrence of the composite of cardiovascular (CV) death or
      heart failure (HF) hospitalization in participants with HFrEF.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 20, 2016</start_date>
  <completion_date type="Actual">September 2, 2019</completion_date>
  <primary_completion_date type="Actual">June 18, 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to First Occurrence of Composite Endpoint of Cardiovascular (CV) Death or Heart Failure (HF) Hospitalization</measure>
    <time_frame>Up to approximately 33 months (through primary analysis database cutoff date of 18-June-2019)</time_frame>
    <description>Time to First Occurrence of Composite Endpoint of CV Death or HF Hospitalization was analyzed using a one-sided stratified log-rank test. Randomized participants without any HF hospitalization or CV death event at the time of analysis were censored at their last available information, the date of their non-CV death, or the primary analysis database cutoff date of 18-June-2019, whichever occurred first. A clinical events committee (CEC) reviewed and adjudicated the endpoint events. A time-to-event methodology was used to evaluate the results; the incidence rate of participants with an event (number of participants with an event per 100 participant-years at risk) is provided.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to the First Occurrence of CV Death</measure>
    <time_frame>Up to approximately 33 months (through primary analysis database cutoff date of 18-June-2019)</time_frame>
    <description>Time to First Occurrence of CV Death was analyzed using a one-sided stratified log-rank test. Randomized participants without a CV death at the time of analysis were censored at their last available information, the date of their non-CV death, or the primary analysis database cutoff date of 18-June-2019, whichever occurred first. A CEC reviewed and adjudicated the endpoint events. A time-to-event methodology was used to evaluate the results; the incidence rate of participants with an event (number of participants with an event per 100 participant-years at risk) is provided.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to the First Occurrence of HF Hospitalization</measure>
    <time_frame>Up to approximately 33 months (through primary analysis database cutoff date of 18-June-2019)</time_frame>
    <description>Time to the First Occurrence of HF Hospitalization was analyzed using a one-sided stratified log-rank test. Randomized participants without any HF hospitalization at the time of analysis were censored at their last available information, the date of their death, or the primary analysis database cutoff date of 18-June-2019, whichever occurred first. A CEC reviewed and adjudicated the endpoint events. A time-to-event methodology was used to evaluate the results; the incidence rate of participants with an event (number of participants with an event per 100 participant-years at risk) is provided.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Total HF Hospitalizations (Including First and Recurrent Events)</measure>
    <time_frame>Up to approximately 33 months (through primary analysis database cutoff date of 18-June-2019)</time_frame>
    <description>Time to Total HF Hospitalizations (including first and recurring) was analyzed using an Andersen-Gill model. Randomized participants without any HF hospitalization at the time of analysis were censored at their last available information, the date of their death, or the primary analysis database cutoff date of 18-June-2019, whichever occurred first. A CEC reviewed and adjudicated the endpoint events. A time-to-event methodology was used to evaluate the results; the incidence rate of participants with an event (number of participants with an event per 100 participant-years of follow-up) is provided.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to First Occurrence of Composite Endpoint of All-Cause Mortality or HF Hospitalization</measure>
    <time_frame>Up to approximately 33 months (through primary analysis database cutoff date of 18-June-2019)</time_frame>
    <description>Time to First Occurrence of Composite Endpoint of All-Cause Mortality or HF Hospitalization was analyzed using a one-sided stratified log-rank test. Randomized participants without any all-cause mortality event or HF hospitalization at the time of analysis were censored at their last available information or the primary analysis database cutoff date of 18-June-2019, whichever occurred first. A CEC reviewed and adjudicated the endpoint events. A time-to-event methodology was used to evaluate the results; the incidence rate of participants with an event (number of participants with an event per 100 participant-years at risk) is provided.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to All-Cause Mortality</measure>
    <time_frame>Up to approximately 33 months (through primary analysis database cutoff date of 18-June-2019)</time_frame>
    <description>Time to All-Cause Mortality was analyzed using a one-sided stratified log-rank test. Randomized participants without any all-cause mortality event at the time of analysis were censored at their last available information or the primary analysis database cutoff date of 18-June-2019, whichever occurred first. A CEC reviewed and adjudicated the endpoint events. A time-to-event methodology was used to evaluate the results: the incidence rate of participants with an event (number of participants with an event per 100 participant-years at risk) is provided.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Who Experienced One or More Adverse Events</measure>
    <time_frame>Up to approximately 33 months (through primary analysis database cutoff date of 18-June-2019)</time_frame>
    <description>An adverse event (AE) is any untoward medical occurrence in a study participant administered a pharmaceutical product that does not necessarily have to have a causal relationship with this treatment. An AE can therefore be any unfavorable and unintended sign, symptom, or disease temporally associated with the use of a medicinal product, whether or not related to the medicinal product.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Who Discontinued Treatment Due to an Adverse Event</measure>
    <time_frame>Up to approximately 33 months (through primary analysis database cutoff date of 18-June-2019)</time_frame>
    <description>An adverse event (AE) is any untoward medical occurrence in a study participant administered a pharmaceutical product that does not necessarily have to have a causal relationship with this treatment. An AE can therefore be any unfavorable and unintended sign, symptom, or disease temporally associated with the use of a medicinal product, whether or not related to the medicinal product.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Who Experienced Symptomatic Hypotension</measure>
    <time_frame>Up to approximately 33 months (through primary analysis database cutoff date of 18-June-2019)</time_frame>
    <description>Study participants were monitored for symptomatic hypotension, an event of clinical interest, and results were reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Who Experienced Syncope</measure>
    <time_frame>Up to approximately 33 months (through primary analysis database cutoff date of 18-June-2019)</time_frame>
    <description>Study participants were monitored for syncope, an event of clinical interest, and results were reported.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">5050</enrollment>
  <condition>Heart Failure</condition>
  <condition>Chronic Heart Failure With Reduced Ejection Fraction</condition>
  <arm_group>
    <arm_group_label>Vericiguat</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants receive a starting dose of 2.5 mg of vericiguat taken orally once daily with food, on a background of HF standard of care. The vericiguat dose will be uptitrated to 5 mg and to 10 mg.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants receive a starting matching placebo dose of 2.5 mg taken orally once daily with food, on a background of HF standard of care. The matching placebo dose will be uptitrated to 5 mg and to 10 mg.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vericiguat</intervention_name>
    <description>2.5, 5.0, or 10.0 mg orally once daily</description>
    <arm_group_label>Vericiguat</arm_group_label>
    <other_name>MK-1242</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo for vericiguat</intervention_name>
    <description>2.5, 5.0, or 10.0 mg orally once daily</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  History of chronic HF (New York Heart Association [NYHA] Class II-IV) on standard
             therapy before qualifying HF decompensation

          -  Previous HF hospitalization within 6 months prior to randomization or intravenous (IV)
             diuretic treatment for HF (without hospitalization) within 3 months.

          -  Brain natriuretic peptide (BNP) levels: sinus rhythm-≥ 300 pg/mL; atrial
             fibrillation-≥ 500 pg/mL and N-terminal pro-Brain Natriuretic Peptide (NT-proBNP)
             levels: sinus rhythm- ≥ 1000 pg/mL; atrial fibrillation - ≥ 1600 pg/mL within 30 days
             prior to randomization

          -  Left ventricular ejection fraction (LVEF) of &lt;45% assessed within 12 months prior to
             randomization by any method

          -  If female, is not of reproductive potential or agrees to avoid becoming pregnant while
             receiving study drug and for 14 days after the last dose of study drug by complying
             with one of the following: practice abstinence from heterosexual activity or use (or
             have her partner use) acceptable contraception during heterosexual activity.

        Exclusion Criteria:

          -  Clinically unstable at the time of randomization as defined by either the
             administration of any IV treatment within 24 hours prior to randomization, and/or
             systolic blood pressure (SBP) &lt;100 mmHg or symptomatic hypotension

          -  Current or anticipated use of long-acting nitrates or nitric oxide (NO) donors
             including isosorbide dinitrate, isosorbide 5-mononitrate, pentaerythritol
             tetranitrate, nicorandil or transdermal nitroglycerin (NTG) patch, and molsidomine

          -  Current or anticipated use of phosphodiesterase type 5 (PDE5) inhibitors such as
             vardenafil, tadalafil, and sildenafil

          -  Current use or anticipated use of a soluble guanylate cyclase (sGC) stimulator such as
             riociguat

          -  Known allergy or sensitivity to any sGC stimulator

          -  Awaiting heart transplantation (United Network for Organ Sharing Class 1A / 1B or
             equivalent), receiving continuous IV infusion of an inotrope, or has/anticipates
             receiving an implanted ventricular assist device

          -  Primary valvular heart disease requiring surgery or intervention, or is within 3
             months after valvular surgery or intervention

          -  Hypertrophic obstructive cardiomyopathy

          -  Acute myocarditis, amyloidosis, sarcoidosis, Takotsubo cardiomyopathy

          -  Post-heart transplant cardiomyopathy

          -  Tachycardia-induced cardiomyopathy and/or uncontrolled tachyarrhythmia

          -  Acute coronary syndrome (unstable angina, non-ST elevation myocardial infarction
             [NSTEMI], or ST elevation myocardial infarction [(STEMI]) or coronary
             revascularization (coronary artery bypass grafting [CABG] or percutaneous coronary
             intervention [PCI]) within 60 days, or indication for coronary revascularization at
             time of randomization

          -  Symptomatic carotid stenosis, transient ischemic attack (TIA) or stroke within 60 days

          -  Complex congenital heart disease

          -  Active endocarditis or constrictive pericarditis

          -  Estimated glomerular filtration rate (eGFR) &lt;15 mL/min/1.73 m2 or chronic dialysis

          -  Severe hepatic insufficiency such as with hepatic encephalopathy

          -  Malignancy or other non-cardiac condition limiting life expectancy to &lt;3 years

          -  Require continuous home oxygen for severe pulmonary disease

          -  Current alcohol and/or drug abuse

          -  Participated in another interventional clinical study and treatment with another
             investigational product ≤30 days prior to randomization or plans to participate in any
             other trial/investigation during the duration of this study

          -  Mental or legal incapacitation and is unable to provide informed consent

          -  Immediate family member (e.g., spouse, parent/legal guardian, sibling or child) who is
             involved with this study

          -  Interstitial Lung Disease

          -  Is pregnant or breastfeeding or plans to become pregnant or to breastfeed during the
             course of the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mahesh J. Patel, MD</last_name>
    <role>Study Director</role>
    <affiliation>Merck Sharp &amp; Dohme Corp.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paul W. Armstrong, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Canadian VIGOUR Centre - University of Alberta</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christopher M. O'Connor, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Inova Heart and Vascular Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Burkert Pieske, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charité University Medicine and German Heart Center</affiliation>
  </overall_official>
  <removed_countries>
    <country>Argentina</country>
    <country>Australia</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Canada</country>
    <country>Chile</country>
    <country>China</country>
    <country>Colombia</country>
    <country>Czech Republic</country>
    <country>Czechia</country>
    <country>Denmark</country>
    <country>Finland</country>
    <country>France</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Guatemala</country>
    <country>Hong Kong</country>
    <country>Hungary</country>
    <country>Ireland</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Japan</country>
    <country>Korea, Republic of</country>
    <country>Malaysia</country>
    <country>Mexico</country>
    <country>Netherlands</country>
    <country>New Zealand</country>
    <country>Norway</country>
    <country>Peru</country>
    <country>Philippines</country>
    <country>Poland</country>
    <country>Puerto Rico</country>
    <country>Russian Federation</country>
    <country>Singapore</country>
    <country>South Africa</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>Switzerland</country>
    <country>Taiwan</country>
    <country>Turkey</country>
    <country>Ukraine</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </removed_countries>
  <results_reference>
    <citation>Pieske B, Patel MJ, Westerhout CM, Anstrom KJ, Butler J, Ezekowitz J, Hernandez AF, Koglin J, Lam CSP, Ponikowski P, Roessig L, Voors AA, O'Connor CM, Armstrong PW; VICTORIA Study Group. Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial. Eur J Heart Fail. 2019 Dec;21(12):1596-1604. doi: 10.1002/ejhf.1664. Epub 2019 Dec 9.</citation>
    <PMID>31820546</PMID>
  </results_reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>August 5, 2016</study_first_submitted>
  <study_first_submitted_qc>August 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 10, 2016</study_first_posted>
  <results_first_submitted>June 11, 2020</results_first_submitted>
  <results_first_submitted_qc>June 11, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">June 29, 2020</results_first_posted>
  <last_update_submitted>July 6, 2020</last_update_submitted>
  <last_update_submitted_qc>July 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>https://thecvc.ca/publications/data-sharing/victoria/</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>December 20, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/34/NCT02861534/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Vericiguat</title>
          <description>Participants received a starting dose of 2.5 mg of vericiguat taken orally once daily with food, on a background of heart failure (HF) standard of care. The vericiguat dose was uptitrated to 5 mg and to 10 mg.</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>Participants received a starting matching placebo dose of 2.5 mg taken orally once daily with food, on a background of HF standard of care. The matching placebo dose was uptitrated to 5 mg and to 10 mg.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="2526"/>
                <participants group_id="P2" count="2524"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Treated</title>
              <participants_list>
                <participants group_id="P1" count="2519"/>
                <participants group_id="P2" count="2515"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1952"/>
                <participants group_id="P2" count="1937"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="574"/>
                <participants group_id="P2" count="587"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="541"/>
                <participants group_id="P2" count="552"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="14"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Site Terminated by Sponsor</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="18"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Vericiguat</title>
          <description>Participants received a starting dose of 2.5 mg of vericiguat taken orally once daily with food, on a background of heart failure (HF) standard of care. The vericiguat dose was uptitrated to 5 mg and to 10 mg.</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>Participants received a starting matching placebo dose of 2.5 mg taken orally once daily with food, on a background of HF standard of care. The matching placebo dose was uptitrated to 5 mg and to 10 mg.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="2526"/>
            <count group_id="B2" value="2524"/>
            <count group_id="B3" value="5050"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67.5" spread="12.2"/>
                    <measurement group_id="B2" value="67.2" spread="12.2"/>
                    <measurement group_id="B3" value="67.3" spread="12.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="605"/>
                    <measurement group_id="B2" value="603"/>
                    <measurement group_id="B3" value="1208"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1921"/>
                    <measurement group_id="B2" value="1921"/>
                    <measurement group_id="B3" value="3842"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="52"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="571"/>
                    <measurement group_id="B2" value="561"/>
                    <measurement group_id="B3" value="1132"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="123"/>
                    <measurement group_id="B2" value="126"/>
                    <measurement group_id="B3" value="249"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1621"/>
                    <measurement group_id="B2" value="1618"/>
                    <measurement group_id="B3" value="3239"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="183"/>
                    <measurement group_id="B2" value="180"/>
                    <measurement group_id="B3" value="363"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Secondary</type>
        <title>Time to the First Occurrence of CV Death</title>
        <description>Time to First Occurrence of CV Death was analyzed using a one-sided stratified log-rank test. Randomized participants without a CV death at the time of analysis were censored at their last available information, the date of their non-CV death, or the primary analysis database cutoff date of 18-June-2019, whichever occurred first. A CEC reviewed and adjudicated the endpoint events. A time-to-event methodology was used to evaluate the results; the incidence rate of participants with an event (number of participants with an event per 100 participant-years at risk) is provided.</description>
        <time_frame>Up to approximately 33 months (through primary analysis database cutoff date of 18-June-2019)</time_frame>
        <population>All randomized participants</population>
        <group_list>
          <group group_id="O1">
            <title>Vericiguat</title>
            <description>Participants received a starting dose of 2.5 mg of vericiguat taken orally once daily with food, on a background of HF standard of care. The vericiguat dose was uptitrated to 5 mg and to 10 mg.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Participants received a starting matching placebo dose of 2.5 mg taken orally once daily with food, on a background of HF standard of care. The matching placebo dose was uptitrated to 5 mg and to 10 mg.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to the First Occurrence of CV Death</title>
          <description>Time to First Occurrence of CV Death was analyzed using a one-sided stratified log-rank test. Randomized participants without a CV death at the time of analysis were censored at their last available information, the date of their non-CV death, or the primary analysis database cutoff date of 18-June-2019, whichever occurred first. A CEC reviewed and adjudicated the endpoint events. A time-to-event methodology was used to evaluate the results; the incidence rate of participants with an event (number of participants with an event per 100 participant-years at risk) is provided.</description>
          <population>All randomized participants</population>
          <units>Parts w/ event per 100 part-yrs at risk</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2526"/>
                <count group_id="O2" value="2524"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.9"/>
                    <measurement group_id="O2" value="13.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.269</p_value>
            <method>Cox proportional hazard model</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.93</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.81</ci_lower_limit>
            <ci_upper_limit>1.06</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to the First Occurrence of HF Hospitalization</title>
        <description>Time to the First Occurrence of HF Hospitalization was analyzed using a one-sided stratified log-rank test. Randomized participants without any HF hospitalization at the time of analysis were censored at their last available information, the date of their death, or the primary analysis database cutoff date of 18-June-2019, whichever occurred first. A CEC reviewed and adjudicated the endpoint events. A time-to-event methodology was used to evaluate the results; the incidence rate of participants with an event (number of participants with an event per 100 participant-years at risk) is provided.</description>
        <time_frame>Up to approximately 33 months (through primary analysis database cutoff date of 18-June-2019)</time_frame>
        <population>All randomized participants</population>
        <group_list>
          <group group_id="O1">
            <title>Vericiguat</title>
            <description>Participants received a starting dose of 2.5 mg of vericiguat taken orally once daily with food, on a background of HF standard of care. The vericiguat dose was uptitrated to 5 mg and to 10 mg.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Participants received a starting matching placebo dose of 2.5 mg taken orally once daily with food, on a background of HF standard of care. The matching placebo dose was uptitrated to 5 mg and to 10 mg.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to the First Occurrence of HF Hospitalization</title>
          <description>Time to the First Occurrence of HF Hospitalization was analyzed using a one-sided stratified log-rank test. Randomized participants without any HF hospitalization at the time of analysis were censored at their last available information, the date of their death, or the primary analysis database cutoff date of 18-June-2019, whichever occurred first. A CEC reviewed and adjudicated the endpoint events. A time-to-event methodology was used to evaluate the results; the incidence rate of participants with an event (number of participants with an event per 100 participant-years at risk) is provided.</description>
          <population>All randomized participants</population>
          <units>Parts w/ event per 100 part-yrs at risk</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2526"/>
                <count group_id="O2" value="2524"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.9"/>
                    <measurement group_id="O2" value="29.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.048</p_value>
            <method>Cox proportional hazard model</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.90</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.81</ci_lower_limit>
            <ci_upper_limit>1.00</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Time to First Occurrence of Composite Endpoint of Cardiovascular (CV) Death or Heart Failure (HF) Hospitalization</title>
        <description>Time to First Occurrence of Composite Endpoint of CV Death or HF Hospitalization was analyzed using a one-sided stratified log-rank test. Randomized participants without any HF hospitalization or CV death event at the time of analysis were censored at their last available information, the date of their non-CV death, or the primary analysis database cutoff date of 18-June-2019, whichever occurred first. A clinical events committee (CEC) reviewed and adjudicated the endpoint events. A time-to-event methodology was used to evaluate the results; the incidence rate of participants with an event (number of participants with an event per 100 participant-years at risk) is provided.</description>
        <time_frame>Up to approximately 33 months (through primary analysis database cutoff date of 18-June-2019)</time_frame>
        <population>All randomized participants</population>
        <group_list>
          <group group_id="O1">
            <title>Vericiguat</title>
            <description>Participants received a starting dose of 2.5 mg of vericiguat taken orally once daily with food, on a background of HF standard of care. The vericiguat dose was uptitrated to 5 mg and to 10 mg.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Participants received a starting matching placebo dose of 2.5 mg taken orally once daily with food, on a background of HF standard of care. The matching placebo dose was uptitrated to 5 mg and to 10 mg.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to First Occurrence of Composite Endpoint of Cardiovascular (CV) Death or Heart Failure (HF) Hospitalization</title>
          <description>Time to First Occurrence of Composite Endpoint of CV Death or HF Hospitalization was analyzed using a one-sided stratified log-rank test. Randomized participants without any HF hospitalization or CV death event at the time of analysis were censored at their last available information, the date of their non-CV death, or the primary analysis database cutoff date of 18-June-2019, whichever occurred first. A clinical events committee (CEC) reviewed and adjudicated the endpoint events. A time-to-event methodology was used to evaluate the results; the incidence rate of participants with an event (number of participants with an event per 100 participant-years at risk) is provided.</description>
          <population>All randomized participants</population>
          <units>Parts w/ event per 100 part-yrs at risk</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2526"/>
                <count group_id="O2" value="2524"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.6" lower_limit="41.5" upper_limit="46.4"/>
                    <measurement group_id="O2" value="37.8" lower_limit="44.4" upper_limit="49.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.019</p_value>
            <method>Cox proportional hazard model</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.90</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.82</ci_lower_limit>
            <ci_upper_limit>0.98</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Total HF Hospitalizations (Including First and Recurrent Events)</title>
        <description>Time to Total HF Hospitalizations (including first and recurring) was analyzed using an Andersen-Gill model. Randomized participants without any HF hospitalization at the time of analysis were censored at their last available information, the date of their death, or the primary analysis database cutoff date of 18-June-2019, whichever occurred first. A CEC reviewed and adjudicated the endpoint events. A time-to-event methodology was used to evaluate the results; the incidence rate of participants with an event (number of participants with an event per 100 participant-years of follow-up) is provided.</description>
        <time_frame>Up to approximately 33 months (through primary analysis database cutoff date of 18-June-2019)</time_frame>
        <population>All randomized participants</population>
        <group_list>
          <group group_id="O1">
            <title>Vericiguat</title>
            <description>Participants received a starting dose of 2.5 mg of vericiguat taken orally once daily with food, on a background of HF standard of care. The vericiguat dose was uptitrated to 5 mg and to 10 mg.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Participants received a starting matching placebo dose of 2.5 mg taken orally once daily with food, on a background of HF standard of care. The matching placebo dose was uptitrated to 5 mg and to 10 mg.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Total HF Hospitalizations (Including First and Recurrent Events)</title>
          <description>Time to Total HF Hospitalizations (including first and recurring) was analyzed using an Andersen-Gill model. Randomized participants without any HF hospitalization at the time of analysis were censored at their last available information, the date of their death, or the primary analysis database cutoff date of 18-June-2019, whichever occurred first. A CEC reviewed and adjudicated the endpoint events. A time-to-event methodology was used to evaluate the results; the incidence rate of participants with an event (number of participants with an event per 100 participant-years of follow-up) is provided.</description>
          <population>All randomized participants</population>
          <units>Parts w/ event per 100 part-yrs</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2526"/>
                <count group_id="O2" value="2524"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.3"/>
                    <measurement group_id="O2" value="42.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.023</p_value>
            <method>Andersen-Gill model</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.91</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.84</ci_lower_limit>
            <ci_upper_limit>0.99</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to First Occurrence of Composite Endpoint of All-Cause Mortality or HF Hospitalization</title>
        <description>Time to First Occurrence of Composite Endpoint of All-Cause Mortality or HF Hospitalization was analyzed using a one-sided stratified log-rank test. Randomized participants without any all-cause mortality event or HF hospitalization at the time of analysis were censored at their last available information or the primary analysis database cutoff date of 18-June-2019, whichever occurred first. A CEC reviewed and adjudicated the endpoint events. A time-to-event methodology was used to evaluate the results; the incidence rate of participants with an event (number of participants with an event per 100 participant-years at risk) is provided.</description>
        <time_frame>Up to approximately 33 months (through primary analysis database cutoff date of 18-June-2019)</time_frame>
        <population>All randomized participants</population>
        <group_list>
          <group group_id="O1">
            <title>Vericiguat</title>
            <description>Participants received a starting dose of 2.5 mg of vericiguat taken orally once daily with food, on a background of HF standard of care. The vericiguat dose was uptitrated to 5 mg and to 10 mg.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Participants received a starting matching placebo dose of 2.5 mg taken orally once daily with food, on a background of HF standard of care. The matching placebo dose was uptitrated to 5 mg and to 10 mg.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to First Occurrence of Composite Endpoint of All-Cause Mortality or HF Hospitalization</title>
          <description>Time to First Occurrence of Composite Endpoint of All-Cause Mortality or HF Hospitalization was analyzed using a one-sided stratified log-rank test. Randomized participants without any all-cause mortality event or HF hospitalization at the time of analysis were censored at their last available information or the primary analysis database cutoff date of 18-June-2019, whichever occurred first. A CEC reviewed and adjudicated the endpoint events. A time-to-event methodology was used to evaluate the results; the incidence rate of participants with an event (number of participants with an event per 100 participant-years at risk) is provided.</description>
          <population>All randomized participants</population>
          <units>Parts w/ event per 100 part-yrs at risk</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2526"/>
                <count group_id="O2" value="2524"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.9"/>
                    <measurement group_id="O2" value="40.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.021</p_value>
            <method>Cox proportional hazard model</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.90</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.83</ci_lower_limit>
            <ci_upper_limit>0.98</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to All-Cause Mortality</title>
        <description>Time to All-Cause Mortality was analyzed using a one-sided stratified log-rank test. Randomized participants without any all-cause mortality event at the time of analysis were censored at their last available information or the primary analysis database cutoff date of 18-June-2019, whichever occurred first. A CEC reviewed and adjudicated the endpoint events. A time-to-event methodology was used to evaluate the results: the incidence rate of participants with an event (number of participants with an event per 100 participant-years at risk) is provided.</description>
        <time_frame>Up to approximately 33 months (through primary analysis database cutoff date of 18-June-2019)</time_frame>
        <population>All randomized participants</population>
        <group_list>
          <group group_id="O1">
            <title>Vericiguat</title>
            <description>Participants received a starting dose of 2.5 mg of vericiguat taken orally once daily with food, on a background of HF standard of care. The vericiguat dose was uptitrated to 5 mg and to 10 mg.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Participants received a starting matching placebo dose of 2.5 mg taken orally once daily with food, on a background of HF standard of care. The matching placebo dose was uptitrated to 5 mg and to 10 mg.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to All-Cause Mortality</title>
          <description>Time to All-Cause Mortality was analyzed using a one-sided stratified log-rank test. Randomized participants without any all-cause mortality event at the time of analysis were censored at their last available information or the primary analysis database cutoff date of 18-June-2019, whichever occurred first. A CEC reviewed and adjudicated the endpoint events. A time-to-event methodology was used to evaluate the results: the incidence rate of participants with an event (number of participants with an event per 100 participant-years at risk) is provided.</description>
          <population>All randomized participants</population>
          <units>Parts w/ event per 100 part-yrs at risk</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2526"/>
                <count group_id="O2" value="2524"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.0"/>
                    <measurement group_id="O2" value="16.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.377</p_value>
            <method>Cox proportional hazard model</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.95</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.84</ci_lower_limit>
            <ci_upper_limit>1.07</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Who Experienced One or More Adverse Events</title>
        <description>An adverse event (AE) is any untoward medical occurrence in a study participant administered a pharmaceutical product that does not necessarily have to have a causal relationship with this treatment. An AE can therefore be any unfavorable and unintended sign, symptom, or disease temporally associated with the use of a medicinal product, whether or not related to the medicinal product.</description>
        <time_frame>Up to approximately 33 months (through primary analysis database cutoff date of 18-June-2019)</time_frame>
        <population>All randomized participants who received at least 1 dose of study treatment</population>
        <group_list>
          <group group_id="O1">
            <title>Vericiguat</title>
            <description>Participants received a starting dose of 2.5 mg of vericiguat taken orally once daily with food, on a background of HF standard of care. The vericiguat dose was uptitrated to 5 mg and to 10 mg.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Participants received a starting matching placebo dose of 2.5 mg taken orally once daily with food, on a background of HF standard of care. The matching placebo dose was uptitrated to 5 mg and to 10 mg.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Experienced One or More Adverse Events</title>
          <description>An adverse event (AE) is any untoward medical occurrence in a study participant administered a pharmaceutical product that does not necessarily have to have a causal relationship with this treatment. An AE can therefore be any unfavorable and unintended sign, symptom, or disease temporally associated with the use of a medicinal product, whether or not related to the medicinal product.</description>
          <population>All randomized participants who received at least 1 dose of study treatment</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2519"/>
                <count group_id="O2" value="2515"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2027"/>
                    <measurement group_id="O2" value="2036"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Who Discontinued Treatment Due to an Adverse Event</title>
        <description>An adverse event (AE) is any untoward medical occurrence in a study participant administered a pharmaceutical product that does not necessarily have to have a causal relationship with this treatment. An AE can therefore be any unfavorable and unintended sign, symptom, or disease temporally associated with the use of a medicinal product, whether or not related to the medicinal product.</description>
        <time_frame>Up to approximately 33 months (through primary analysis database cutoff date of 18-June-2019)</time_frame>
        <population>All randomized participants who received at least 1 dose of study treatment</population>
        <group_list>
          <group group_id="O1">
            <title>Vericiguat</title>
            <description>Participants received a starting dose of 2.5 mg of vericiguat taken orally once daily with food, on a background of HF standard of care. The vericiguat dose was uptitrated to 5 mg and to 10 mg.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Participants received a starting matching placebo dose of 2.5 mg taken orally once daily with food, on a background of HF standard of care. The matching placebo dose was uptitrated to 5 mg and to 10 mg.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Discontinued Treatment Due to an Adverse Event</title>
          <description>An adverse event (AE) is any untoward medical occurrence in a study participant administered a pharmaceutical product that does not necessarily have to have a causal relationship with this treatment. An AE can therefore be any unfavorable and unintended sign, symptom, or disease temporally associated with the use of a medicinal product, whether or not related to the medicinal product.</description>
          <population>All randomized participants who received at least 1 dose of study treatment</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2519"/>
                <count group_id="O2" value="2515"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="167"/>
                    <measurement group_id="O2" value="158"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants Who Experienced Symptomatic Hypotension</title>
        <description>Study participants were monitored for symptomatic hypotension, an event of clinical interest, and results were reported.</description>
        <time_frame>Up to approximately 33 months (through primary analysis database cutoff date of 18-June-2019)</time_frame>
        <population>All randomized participants who received at least 1 dose of study treatment</population>
        <group_list>
          <group group_id="O1">
            <title>Vericiguat</title>
            <description>Participants received a starting dose of 2.5 mg of vericiguat taken orally once daily with food, on a background of HF standard of care. The vericiguat dose was uptitrated to 5 mg and to 10 mg.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Participants received a starting matching placebo dose of 2.5 mg taken orally once daily with food, on a background of HF standard of care. The matching placebo dose was uptitrated to 5 mg and to 10 mg.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Who Experienced Symptomatic Hypotension</title>
          <description>Study participants were monitored for symptomatic hypotension, an event of clinical interest, and results were reported.</description>
          <population>All randomized participants who received at least 1 dose of study treatment</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2519"/>
                <count group_id="O2" value="2515"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.1"/>
                    <measurement group_id="O2" value="7.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.121</p_value>
            <method>Miettinen &amp; Nurminen method</method>
            <param_type>Difference in Percentage</param_type>
            <param_value>1.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.3</ci_lower_limit>
            <ci_upper_limit>2.8</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants Who Experienced Syncope</title>
        <description>Study participants were monitored for syncope, an event of clinical interest, and results were reported.</description>
        <time_frame>Up to approximately 33 months (through primary analysis database cutoff date of 18-June-2019)</time_frame>
        <population>All randomized participants who received at least 1 dose of study treatment</population>
        <group_list>
          <group group_id="O1">
            <title>Vericiguat</title>
            <description>Participants received a starting dose of 2.5 mg of vericiguat taken orally once daily with food, on a background of HF standard of care. The vericiguat dose was uptitrated to 5 mg and to 10 mg.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Participants received a starting matching placebo dose of 2.5 mg taken orally once daily with food, on a background of HF standard of care. The matching placebo dose was uptitrated to 5 mg and to 10 mg.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Who Experienced Syncope</title>
          <description>Study participants were monitored for syncope, an event of clinical interest, and results were reported.</description>
          <population>All randomized participants who received at least 1 dose of study treatment</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2519"/>
                <count group_id="O2" value="2515"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.0"/>
                    <measurement group_id="O2" value="3.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.303</p_value>
            <method>Miettinen &amp; Nurminen method</method>
            <param_type>Difference in Percentage</param_type>
            <param_value>0.6</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.5</ci_lower_limit>
            <ci_upper_limit>1.6</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Up to approximately 35 months (through Last Subject Last Visit date of 02-Sept-2019)</time_frame>
      <desc>Serious Adverse Events and Other Adverse Events: All randomized participants who received at least 1 dose of study treatment
All-Cause Mortality: All randomized participants</desc>
      <group_list>
        <group group_id="E1">
          <title>Vericiguat</title>
          <description>Participants received a starting dose of 2.5 mg of vericiguat taken orally once daily with food, on a background of HF standard of care. The vericiguat dose was uptitrated to 5 mg and to 10 mg.</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>Participants received a starting matching placebo dose of 2.5 mg taken orally once daily with food, on a background of HF standard of care. The matching placebo dose was uptitrated to 5 mg and to 10 mg.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 22.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="553" subjects_at_risk="2526"/>
                <counts group_id="E2" subjects_affected="561" subjects_at_risk="2524"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="852" subjects_at_risk="2519"/>
                <counts group_id="E2" subjects_affected="897" subjects_at_risk="2515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="50" subjects_affected="41" subjects_at_risk="2519"/>
                <counts group_id="E2" events="25" subjects_affected="24" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Anaemia of chronic disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Autoimmune haemolytic anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Bicytopenia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Blood loss anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Bone marrow failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Coagulopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Disseminated intravascular coagulation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hypocoagulable state</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Iron deficiency anaemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Normochromic normocytic anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Normocytic anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pancytopenia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Splenic infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute coronary syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="2519"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" events="10" subjects_affected="9" subjects_at_risk="2519"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Angina unstable</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="13" subjects_affected="7" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Aortic valve calcification</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Aortic valve incompetence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Aortic valve stenosis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2519"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis coronary artery</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="15" subjects_affected="14" subjects_at_risk="2519"/>
                <counts group_id="E2" events="31" subjects_affected="29" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="2519"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Atrial tachycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Atrial thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Atrioventricular block</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Atrioventricular block complete</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Atrioventricular block second degree</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Bradyarrhythmia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2519"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Bundle branch block left</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2519"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cardiac asthma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" events="88" subjects_affected="82" subjects_at_risk="2519"/>
                <counts group_id="E2" events="128" subjects_affected="116" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cardiac failure acute</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cardiac failure chronic</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="2519"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="2519"/>
                <counts group_id="E2" events="25" subjects_affected="25" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cardiac perforation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cardiac ventricular thrombosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cardio-respiratory arrest</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cardiogenic shock</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="2519"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cardiopulmonary failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cardiorenal syndrome</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cardiovascular disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cardiovascular insufficiency</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Congestive cardiomyopathy</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2519"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="2519"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Coronary artery occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Coronary artery stenosis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Extrasystoles</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Heart valve incompetence</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Intracardiac thrombus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Ischaemic cardiomyopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Left ventricular dysfunction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Left ventricular failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Mitral valve incompetence</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="2519"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="2519"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Myocardial ischaemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pericardial effusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pericarditis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Sinus bradycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Sinus node dysfunction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Tachyarrhythmia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Ventricular arrhythmia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Ventricular dysfunction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Ventricular extrasystoles</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Ventricular fibrillation</sub_title>
                <counts group_id="E1" events="10" subjects_affected="9" subjects_at_risk="2519"/>
                <counts group_id="E2" events="9" subjects_affected="7" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" events="18" subjects_affected="14" subjects_at_risk="2519"/>
                <counts group_id="E2" events="29" subjects_affected="27" subjects_at_risk="2515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Corneal dystrophy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Gastrointestinal arteriovenous malformation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hydrocele</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Phimosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pyloric stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2519"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Vertigo positional</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="2515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Basedow's disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Carcinoid syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Glucocorticoid deficiency</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hyperthyroidism</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hypoparathyroidism secondary</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hypothyroidism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Blindness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" events="10" subjects_affected="9" subjects_at_risk="2519"/>
                <counts group_id="E2" events="8" subjects_affected="6" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Diabetic retinopathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Diplopia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Eye haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Eyelid ptosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Glaucoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Macular cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Retinal artery thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Retinal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Vitreous haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal distension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="2519"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Abdominal pain lower</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="2519"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Abdominal rigidity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Alcoholic pancreatitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Anorectal ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" events="10" subjects_affected="8" subjects_at_risk="2519"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Barrett's oesophagus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Colitis ischaemic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Dental caries</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Dental cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="2519"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Diverticulum</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Erosive oesophagitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Faecaloma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Gastric haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Gastric perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Gastric ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Gastric ulcer haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="2519"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Gastritis erosive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Gastritis haemorrhagic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Gastrointestinal angiodysplasia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="14" subjects_affected="12" subjects_at_risk="2519"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Gastrointestinal toxicity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Gingival bleeding</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Haematemesis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Haematochezia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Haemorrhoidal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Impaired gastric emptying</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Incarcerated inguinal hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Incarcerated umbilical hernia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="2519"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Inguinal hernia strangulated</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Inguinal hernia, obstructive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Intestinal infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Intestinal ischaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Intra-abdominal haematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Ischaemic enteritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Large intestinal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Large intestinal obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Large intestinal stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Large intestinal ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Large intestinal ulcer haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Large intestinal ulcer perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Large intestine polyp</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Lower gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Melaena</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Obstructive pancreatitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Oesophageal achalasia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Oesophageal stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Oesophageal varices haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pancreatitis acute</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pancreatitis chronic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pancreatolithiasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Peptic ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pneumatosis intestinalis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Rectal haemorrhage</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Subileus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Umbilical hernia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Upper gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2519"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="2519"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cardiac complication associated with device</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="2519"/>
                <counts group_id="E2" events="14" subjects_affected="8" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Device related thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Discomfort</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>General physical health deterioration</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Generalised oedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hernia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Impaired healing</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Implant site erythema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Implant site haematoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Implant site haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Influenza like illness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Medical device pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Medical device site haematoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Medical device site swelling</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Medical device site thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Multiple organ dysfunction syndrome</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="2519"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Physical deconditioning</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Sensation of foreign body</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Strangulated hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Sudden cardiac death</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>UGT1A1 gene polymorphism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Vascular stent occlusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Vascular stent stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Vascular stent thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute hepatic failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Bile duct stone</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Biloma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cholangitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cholangitis acute</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="2519"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cholecystitis acute</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="2519"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cholecystitis chronic</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cholestasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Chronic hepatic failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hepatic cirrhosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hepatic congestion</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hepatic failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hepatitis acute</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hepatitis toxic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hepatocellular injury</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Ischaemic hepatitis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Jaundice cholestatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Liver disorder</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Liver injury</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Portosplenomesenteric venous thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Amyloidosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abscess limb</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Acinetobacter bacteraemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Amoebic dysentery</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Anal abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Arteriovenous fistula site infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Atypical pneumonia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Bacteraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Bacterial sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="2519"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Bronchitis viral</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Campylobacter gastroenteritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="27" subjects_affected="25" subjects_at_risk="2519"/>
                <counts group_id="E2" events="20" subjects_affected="19" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cellulitis gangrenous</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Chest wall abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cholecystitis infective</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Chronic sinusitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Clostridium difficile colitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Complicated appendicitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cystitis bacterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Device related infection</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Diabetic foot infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Diarrhoea infectious</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Disseminated tuberculosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Endocarditis</sub_title>
                <counts group_id="E1" events="7" subjects_affected="4" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Enteritis infectious</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Enterobacter bacteraemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Enterococcal bacteraemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Enterococcal infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Enterocolitis viral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Epididymitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Erysipelas</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Escherichia urinary tract infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Extradural abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Eye infection bacterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Febrile infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Fungaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Gangrene</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="2519"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Gas gangrene</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" events="16" subjects_affected="16" subjects_at_risk="2519"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Gastroenteritis bacterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Gastroenteritis norovirus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Gastroenteritis salmonella</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Groin abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>H1N1 influenza</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Haematoma infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Herpes zoster</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Implant site cellulitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Implant site infection</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2519"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Infected bite</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Infected skin ulcer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Infectious pleural effusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Infective exacerbation of chronic obstructive airways disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="2519"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Intervertebral discitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Intestinal sepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Klebsiella sepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Liver abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Localised infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="2519"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection viral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Lung infection</sub_title>
                <counts group_id="E1" events="12" subjects_affected="10" subjects_at_risk="2519"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Measles</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Medical device site abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Myocarditis infectious</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Necrotising fasciitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Nosocomial infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Ophthalmic herpes zoster</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="2519"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Osteomyelitis acute</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Osteomyelitis chronic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Otitis externa</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Parainfluenzae virus infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Parotid abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Periodontitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Perirectal abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Peritonitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Peritonitis bacterial</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pertussis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="113" subjects_affected="104" subjects_at_risk="2519"/>
                <counts group_id="E2" events="127" subjects_affected="116" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pneumonia bacterial</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2519"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pneumonia chlamydial</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pneumonia mycoplasmal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pneumonia pneumococcal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pneumonia respiratory syncytial viral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pneumonia staphylococcal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pneumonia streptococcal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pneumonia viral</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Postoperative wound infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pseudomembranous colitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Psoas abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pulmonary sepsis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pyelonephritis acute</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pyelonephritis chronic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Renal abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="2519"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection viral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Salmonella bacteraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" events="16" subjects_affected="16" subjects_at_risk="2519"/>
                <counts group_id="E2" events="25" subjects_affected="25" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Septic shock</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="2519"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Serratia bacteraemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Skin bacterial infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Skin infection</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Staphylococcal bacteraemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Staphylococcal infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Staphylococcal sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Staphylococcal skin infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Streptococcal bacteraemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Subcutaneous abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Systemic candida</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis septic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Tooth abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Tracheobronchitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Tuberculous pleurisy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Typhoid fever</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="2519"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Ureter abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="23" subjects_affected="20" subjects_at_risk="2519"/>
                <counts group_id="E2" events="18" subjects_affected="16" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Vestibular neuronitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Viral diarrhoea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Viral upper respiratory tract infection</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>West Nile viral infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Wound infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Wound sepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Accidental overdose</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Acetabulum fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Alcohol poisoning</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Arterial bypass occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Arteriovenous fistula site complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Asbestosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Bone fissure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Burns second degree</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Burns third degree</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cardiac valve replacement complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cervical vertebral fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Chest injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Coronary vascular graft stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Costal cartilage fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Craniocerebral injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Facial bones fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="2519"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Femoral neck fracture</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2519"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Fibula fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Foot fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Head injury</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Heat illness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hip fracture</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="2519"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Humerus fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Incision site haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Limb crushing injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Limb injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Lower limb fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Lumbar vertebral fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Multiple injuries</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Overdose</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Patella fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pelvic fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Penis injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Post procedural haematuria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Post procedural haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Post procedural hypothyroidism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Postoperative hypotension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pubis fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Radius fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Sedation complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Seroma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Skin laceration</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Snake bite</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Spinal compression fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Spinal fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Subdural haematoma</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Subdural haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Suture related complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Tendon rupture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Thermal burn</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Thoracic vertebral fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Tibia fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Toxicity to various agents</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Traumatic fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Traumatic liver injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Traumatic ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Upper limb fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Urinary retention postoperative</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Vascular graft occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Vascular pseudoaneurysm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Vasoplegia syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Wrist fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Alanine aminotransferase increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Angiocardiogram</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Anticoagulation drug level above therapeutic</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Aspartate aminotransferase increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Blood bilirubin increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Blood creatinine increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Blood potassium increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Blood sodium decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Blood urea increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Bone density abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cardiac index abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cardiac stress test abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Catheterisation cardiac</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cortisol decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Ejection fraction decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Gamma-glutamyltransferase increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Haemoglobin decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Heart rate irregular</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hepatic enzyme abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hepatic enzyme increased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Influenza A virus test positive</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>International normalised ratio increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Liver function test abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Liver function test increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Occult blood positive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Transaminases increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Troponin increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Weight increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Cachexia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="2519"/>
                <counts group_id="E2" events="13" subjects_affected="12" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="2519"/>
                <counts group_id="E2" events="11" subjects_affected="10" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus inadequate control</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Diabetes with hyperosmolarity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Diabetic ketoacidosis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Diabetic metabolic decompensation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Fluid overload</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" events="12" subjects_affected="10" subjects_at_risk="2519"/>
                <counts group_id="E2" events="14" subjects_affected="12" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hyperammonaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hypercalcaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="2519"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hyperglycaemic hyperosmolar nonketotic syndrome</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="2519"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hypernatraemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hyperosmolar state</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hypoalbuminaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hypocalcaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hypochloraemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" events="13" subjects_affected="12" subjects_at_risk="2519"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="2519"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hypomagnesaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="2519"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hypophosphataemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hypovolaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Ketoacidosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Marasmus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Metabolic acidosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Metabolic alkalosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Mineral metabolism disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Type 2 diabetes mellitus</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="2519"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="2515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="2519"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cervical spinal stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Chondritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Enthesopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Gouty arthritis</sub_title>
                <counts group_id="E1" events="9" subjects_affected="7" subjects_at_risk="2519"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Gouty tophus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Haematoma muscle</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Intervertebral disc disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Lumbar spinal stenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Osteonecrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pathological fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Polyarthritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Rhabdomyolysis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Rheumatoid arthritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Sjogren's syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Spinal pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Spinal stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Spondylitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Tendonitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Adenocarcinoma gastric</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma of colon</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma pancreas</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Adrenal gland cancer metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Angiocentric lymphoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Basal cell carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Benign gastric neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Benign neoplasm of bladder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Bladder cancer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Bladder cancer recurrent</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Bladder neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Bladder transitional cell carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Bowen's disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Bronchial carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Chronic lymphocytic leukaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Colon adenoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Colon cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Colon neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cutaneous T-cell lymphoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Diffuse large B-cell lymphoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Gastric cancer</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Glioblastoma multiforme</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hepatic cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hepatic cancer metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hepatic neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hepatobiliary cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hepatocellular carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Inflammatory pseudotumour</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Lung cancer metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Lung neoplasm malignant</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Lymphoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Lymphoproliferative disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Malignant melanoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Meningioma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Metastases to abdominal cavity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Metastases to bone</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Metastases to central nervous system</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Metastases to lung</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Metastases to lymph nodes</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Metastatic neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Myelodysplastic syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Oesophageal carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Oropharyngeal cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Oropharyngeal squamous cell carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Ovarian cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Plasma cell myeloma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Plasmacytoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Polycythaemia vera</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Prostate cancer metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Rectal cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Rectosigmoid cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Renal cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Renal neoplasm</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Retroperitoneal cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Skin cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of head and neck</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of lung</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of the oral cavity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Sweat gland tumour</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>T-cell lymphoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Tongue neoplasm malignant stage unspecified</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Tumour ulceration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Uterine cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Uterine leiomyoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Waldenstrom's macroglobulinaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Altered state of consciousness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Autonomic neuropathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Axonal neuropathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Brain hypoxia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Brain injury</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Brain oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Carotid artery stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cauda equina syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cerebral artery embolism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cerebral artery stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cerebral haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cerebral ischaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2519"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cerebrovascular disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cognitive disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Coma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Dementia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Dementia Alzheimer's type</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Diabetic neuropathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Dizziness postural</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Dysarthria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Facial paralysis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Generalised tonic-clonic seizure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hemiparesis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hepatic encephalopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hydrocephalus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hypoxic-ischaemic encephalopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Ischaemic stroke</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Lethargy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Loss of consciousness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Lumbar radiculopathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Metabolic encephalopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Myelopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Myoclonus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Neuropathy peripheral</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Post stroke epilepsy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Seizure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Spinal cord compression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Status epilepticus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Subarachnoid haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="45" subjects_affected="43" subjects_at_risk="2519"/>
                <counts group_id="E2" events="35" subjects_affected="33" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Tension headache</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Toxic encephalopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Vascular dementia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Vertebrobasilar insufficiency</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Device battery issue</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Device dislocation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Device failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Device ineffective</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Device malfunction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Lead dislodgement</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Alcohol abuse</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Anxiety disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Delirium</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Drug use disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Panic attack</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Suicide attempt</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute kidney injury</sub_title>
                <counts group_id="E1" events="69" subjects_affected="66" subjects_at_risk="2519"/>
                <counts group_id="E2" events="53" subjects_affected="51" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Azotaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Bladder cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Bladder mass</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Calculus bladder</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Chronic kidney disease</sub_title>
                <counts group_id="E1" events="42" subjects_affected="40" subjects_at_risk="2519"/>
                <counts group_id="E2" events="31" subjects_affected="31" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Costovertebral angle tenderness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>End stage renal disease</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2519"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Nephritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Nephropathy</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Nephrotic syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Renal artery stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Renal colic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Renal cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" events="25" subjects_affected="24" subjects_at_risk="2519"/>
                <counts group_id="E2" events="31" subjects_affected="30" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Renal impairment</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="2519"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Renal infarct</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Renal mass</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Urate nephropathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Ureterolithiasis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Urethral stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Benign prostatic hyperplasia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Endometrial hyperplasia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute pulmonary oedema</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="2519"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="2519"/>
                <counts group_id="E2" events="6" subjects_affected="4" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Atelectasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Bronchial haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Bronchitis chronic</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Bronchospasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" events="51" subjects_affected="38" subjects_at_risk="2519"/>
                <counts group_id="E2" events="50" subjects_affected="30" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Chylothorax</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="2519"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Dyspnoea exertional</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Haemothorax</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hyperventilation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Interstitial lung disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Obstructive airways disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" events="8" subjects_affected="6" subjects_at_risk="2519"/>
                <counts group_id="E2" events="15" subjects_affected="13" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pleurisy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pleuritic pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pneumonia aspiration</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pulmonary congestion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="2519"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pulmonary haematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pulmonary hypertension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pulmonary infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pulmonary mass</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Pulmonary oedema</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="2519"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Respiratory disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="2519"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Rhinitis hypertrophic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Sleep apnoea syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Tonsillar haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Angioedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Dermatitis bullous</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Diabetic foot</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Drug eruption</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Ecchymosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Haemorrhage subcutaneous</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Henoch-Schonlein purpura</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Neurodermatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Psoriasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Skin necrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="2519"/>
                <counts group_id="E2" events="14" subjects_affected="9" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Stasis dermatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Stevens-Johnson syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Aortic aneurysm repair</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Arrhythmia prophylaxis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cardiac pacemaker replacement</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cardiac rehabilitation therapy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cardiac resynchronisation therapy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cardiovascular event prophylaxis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Cardioversion</sub_title>
                <counts group_id="E1" events="3" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Central venous catheter removal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Gastrectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Implantable defibrillator insertion</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Implantable defibrillator removal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Implantable defibrillator replacement</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Inguinal hernia repair</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Intraocular lens implant</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Leg amputation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Nephroprotective therapy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Therapeutic procedure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Toe operation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Aortic aneurysm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Aortic dissection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Aortic stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Arterial occlusive disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Bleeding varicose vein</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Circulatory collapse</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Diabetic vascular disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Dry gangrene</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Extremity necrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="2519"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Haemorrhagic vasculitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="2519"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hypertensive crisis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="34" subjects_affected="33" subjects_at_risk="2519"/>
                <counts group_id="E2" events="45" subjects_affected="44" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Hypovolaemic shock</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Iliac artery occlusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Intermittent claudication</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Ischaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Lymphorrhoea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Orthostatic hypotension</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Peripheral arterial occlusive disease</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="2519"/>
                <counts group_id="E2" events="12" subjects_affected="11" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Peripheral artery occlusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Peripheral artery stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Peripheral artery thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Peripheral embolism</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Peripheral ischaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="2519"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Peripheral vascular disorder</sub_title>
                <counts group_id="E1" events="6" subjects_affected="4" subjects_at_risk="2519"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Peripheral venous disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Shock</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Shock haemorrhagic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Varicose vein</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Varicose vein ruptured</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
              <event>
                <sub_title>Vascular occlusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="2519"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="2515"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA 22.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="958" subjects_at_risk="2519"/>
                <counts group_id="E2" subjects_affected="925" subjects_at_risk="2515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="181" subjects_affected="165" subjects_at_risk="2519"/>
                <counts group_id="E2" events="139" subjects_affected="134" subjects_at_risk="2515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" events="219" subjects_affected="160" subjects_at_risk="2519"/>
                <counts group_id="E2" events="221" subjects_affected="157" subjects_at_risk="2515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="141" subjects_affected="127" subjects_at_risk="2519"/>
                <counts group_id="E2" events="136" subjects_affected="120" subjects_at_risk="2515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" events="153" subjects_affected="126" subjects_at_risk="2519"/>
                <counts group_id="E2" events="163" subjects_affected="131" subjects_at_risk="2515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" events="124" subjects_affected="112" subjects_at_risk="2519"/>
                <counts group_id="E2" events="167" subjects_affected="138" subjects_at_risk="2515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="195" subjects_affected="169" subjects_at_risk="2519"/>
                <counts group_id="E2" events="169" subjects_affected="152" subjects_at_risk="2515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="161" subjects_affected="127" subjects_at_risk="2519"/>
                <counts group_id="E2" events="158" subjects_affected="132" subjects_at_risk="2515"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="487" subjects_affected="369" subjects_at_risk="2519"/>
                <counts group_id="E2" events="437" subjects_affected="331" subjects_at_risk="2515"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The Sponsor must have the opportunity to review all proposed abstracts, manuscripts or presentations regarding this trial 45 days prior to submission for publication/presentation. Any information identified by the Sponsor as confidential must be deleted prior to submission; this confidentiality does not include efficacy and safety results. Sponsor review can be expedited to meet publication timelines.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Senior Vice President, Global Clinical Development</name_or_title>
      <organization>Merck Sharp &amp; Dohme Corp.</organization>
      <phone>1-800-672-6372</phone>
      <email>ClinicalTrialsDisclosure@merck.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

